Figure 6.
Inflamed mucosa of progressors is characterised by fewer B cells and lymphoid aggregates. (a) and b) Scatter plots showing the percentage of CD20 positive cells and CD3 positive cells, respectively, in inflamed samples of non-progressors and progressors assessed by IHC. (c) Column bar plot showing the percentage of inflamed samples with lymphoid aggregates in the mucosa of non-progressors and progressors. (d) Scatter plot showing the number of lymphoid aggregates per inflamed sample of non-progressors and progressors. (e) and (f) Scatter plot showing the number of lymphoid aggregates per chronic and chronic inflamed sample, respectively, of non-progressors and progressors. In (a,b,d,e and f) the median for each group is indicated by a red line. A two-tailed t-test was performed for comparison of two groups in (a,b,d,e and f) and a two-sided Fisher’s Exact test was performed for c). P-values below 0.05 were considered significant.